Rare Wolf Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Rare Wolf Capital's VRTX Position: Q2 2026 in Review
Rare Wolf Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q2 2026, selling an estimated $176K and leaving 2,028 shares worth $1.01M. The position accounts for 0.65% of the portfolio, ranked #37.
Rare Wolf Capital first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q1 2026. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Rare Wolf Capital held 2,028 shares of Vertex Pharmaceuticals worth $1.01M as of Q2 2026.
- Rare Wolf Capital sold 397 Vertex Pharmaceuticals shares in Q2 2026, an estimated $176K.
- Vertex Pharmaceuticals made up 0.65% of Rare Wolf Capital's portfolio in Q2 2026, its #37 holding.
- Rare Wolf Capital first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Rare Wolf Capital's Vertex Pharmaceuticals position peaked at $1.08M in Q1 2026.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Rare Wolf Capital's 13F filing for Q2 2026, filed 24 Jul 2026.